Skip to main content

Table 3 Increased levels of soluble Aβ40/42 in the neocortex of APPswe/PS1dE9 mice

From: Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease

 

40

42

40:42

(pg/mg total protein)

(pg/mg total protein)

WT

TG

WT

TG

TG

3 months

3.7 ± 0.9

44.3 ± 3.5

1.6 ± 0.4

14.8 ± 2.8

3.2 ± 0.3

6 months

2.6 ± 0.6

90.0 ± 12.5

0.8 ± 0.1

55.4 ± 13.2

1.9 ± 0.2**, ##

12 months

4.2 ± 1.5

306.2 ± 38.5

1.7 ± 0.6

197.0 ± 26.3

1.6 ± 0.1*, ###

20 months

2.8 ± 1.2

1031.2 ± 184.4***

1.1 ± 0.4

340.6 ± 81.6***

3.4 ± 0.4

  1. Soluble amyloid-β (Aβ) was measured in the S1 supernatant fraction from neocortical homogenates of aging wild-type (WT) and APPswe/PS1dE9 transgenic (TG) mice, by using Meso Scale Discovery. Aβ40/42 values were normalized to total protein content and reported as the mean ± SEM of 3–4 independent experiments. Age-dependent increases in the concentration of soluble Aβ40/42 were observed exclusively in APPswe/PS1de9 mice. The proportion of Aβ40 in the Aβ40:Aβ42 ratio increased in 20- vs. 6- and 12-month-old TG mice. *p < 0.05, **p < 0.01, and ***p < 0.001 vs. 3-month-old TG mice, two-way ANOVA followed by Bonferroni posttests; ##p < 0.01 and ###p < 0.001 vs. 20-month-old TG mice, one-way ANOVA followed by Bonferroni posttests